# Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

> **NCT04447833** · PHASE1 · COMPLETED · sponsor: **Uppsala University** · enrollment: 7 (actual)

## Conditions studied

- ARDS, Human
- COVID

## Interventions

- **DRUG:** Mesenchymal Stromal Stem Cells - KI-MSC-PL-205

## Key facts

- **NCT ID:** NCT04447833
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-17
- **Primary completion:** 2021-01-30
- **Final completion:** 2026-04-15
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04447833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04447833, "Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04447833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*